Opsoclonus-Myoclonus Syndrome (OMS) (pediatric neurology | worldwide)


The Opsoclonus-Myoclonus Syndrome (OMS)  from The Pablove Foundation supports pediatric neurology researchers working on the rare disease Opsoclonus-Myoclonus Syndrome (OMS). Applicants may be based anywhere in the world. Applicants must hold an MD or PhD. The Grant provides funding of 100,000 USD over 2 years. Upon timely submission of the required deliverables, an additional 5% of the award amount (up to $2,500) will be provided to the sponsoring institutions to cover indirect costs (F&A) at the end of the grant’s performance period.

Letters of intent are due on July 6, 2023. Invited full applications are due on October 5, 2023.


Be the first to know

Sign-up for Personalized Grant alerts

Sign-up for the
monthly research
funding newsletter

You can unsubscribe at any time.